UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 104

Sortiert nach

Impact of the 2008 economic crisis on the burden of hepatitis B and C diseases in Southern European countries

BMC public health, 2024-06, Vol.24 (1), p.1-70, Article 1642

2024

Volltextzugriff (PDF)

Epidemic history of hepatitis C virus genotypes and subtypes in Portugal

Scientific reports, 2018-08, Vol.8 (1), p.12266-13, Article 12266

2018

Volltextzugriff (PDF)

HIV-1 diversity, transmission dynamics and primary drug resistance in Angola

PloS one, 2014-12, Vol.9 (12), p.e113626-e113626

2014

Volltextzugriff (PDF)

Early infant diagnosis of HIV-1 infection in Luanda, Angola, using a new DNA PCR assay and dried blood spots

PloS one, 2017-07, Vol.12 (7), p.e0181352-e0181352

2017

Volltextzugriff (PDF)

Long-Term and Low-Level Envelope C2V3 Stimulation by Highly Diverse Virus Isolates Leads to Frequent Development of Broad and Elite Antibody Neutralization in HIV-1-Infected Individuals

Microbiology spectrum, 2022-12, Vol.10 (6), p.e0163422-e0163422

2022

Volltextzugriff (PDF)

Low frequency of NS5A relevant resistance-associated substitutions to Elbasvir among hepatitis C virus genotype 1a in Spain: a cross-sectional study

Scientific reports, 2017-06, Vol.7 (1), p.2892-6, Article 2892

2017

Volltextzugriff (PDF)

Predictors of attrition and immunological failure in HIV-1 patients on highly active antiretroviral therapy from different healthcare settings in Mozambique

PloS one, 2013-12, Vol.8 (12), p.e82718-e82718

2013

Volltextzugriff (PDF)

A Conserved GPG-Motif in the HIV-1 Nef Core Is Required for Principal Nef-Activities

PloS one, 2015-12, Vol.10 (12), p.e0145239-e0145239

2015

Volltextzugriff (PDF)

Dynamics of HIV Reservoir and HIV-1 Viral Splicing in HCV-Exposed Individuals after Elimination with DAAs or Spontaneous Clearance

Journal of clinical medicine, 2022-06, Vol.11 (13), p.3579

2022

Volltextzugriff (PDF)

Determinants of highly active antiretroviral therapy duration in HIV-1-infected children and adolescents in Madrid, Spain, from 1996 to 2012

PloS one, 2014-05, Vol.9 (5), p.e96307-e96307

2014

Volltextzugriff (PDF)

Scorpion envenomation in Argentina

Archivos argentinos de pediatría, 2010-04, Vol.108 (2), p.161-167

2010

Volltextzugriff (PDF)

HIV-1 drug resistance and genetic diversity in people with HIV-1 in Cape Verde

AIDS (London), 2024-07, Vol.38 (8), p.1101

2024

Volltextzugriff (PDF)

Prioritizing the most needed formulations to accelerate paediatric antiretroviral therapy scale-up

Current opinion in HIV & AIDS, 2017-07, Vol.12 (4), p.369

2017

Volltextzugriff (PDF)

Envenenamiento por escorpión en la Argentina

Archivos argentinos de pediatría, 2010-04, Vol.108 (2), p.161-167

2010

Volltextzugriff (PDF)

Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention

PloS one, 2014-07, Vol.9 (7), p.e103345

2014

Volltextzugriff (PDF)

Impact of highly active antiretroviral therapy (HAART) on clinical outcomes of vertically HIV-1 infected children

Retrovirology, 2008-04, Vol.5 (Suppl 1), p.P14-P14

2008

Volltextzugriff (PDF)

Epidemic history and baseline resistance to NS5A-specific direct acting drugs of hepatitis C virus in Spain

Scientific reports, 2020-08, Vol.10 (1), p.13024-13024, Article 13024

2020

Volltextzugriff (PDF)

Spatial pattern of HIV-1 cases of vertical transmission in Madrid (Spain): impact of demographic and socioeconomic factors

Retrovirology, 2008-04, Vol.5 (Suppl 1), p.P23

2008

Volltextzugriff (PDF)

HCV-coinfection is related to an increased HIV-1 reservoir size in cART-treated HIV patients: a cross-sectional study

Scientific reports, 2019-04, Vol.9 (1), p.5606, Article 5606

2019

Volltextzugriff (PDF)

Frecuencia de sustituciones relevantes asociadas a resistencia en la región NS5A a elbasvir en el virus de la hepatitis C en pacientes con genotipo 1a en España

Enfermedades infecciosas y microbiología clínica, 2018-05, Vol.36 (5), p.262-267

2018

Volltextzugriff (PDF)

Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019

The Lancet. Public health, 2023-09, Vol.8 (9), p.e701-e716

2023

Volltextzugriff (PDF)

Off-label use of maraviroc in HIV-1-infected paediatric patients in clinical practice

AIDS (London), 2015-10, Vol.29 (16), p.2155-2159

2015

Volltextzugriff (PDF)

Prevalence of relevant NS5A resistance-associated substitutions to elbasvir in genotype 1a hepatitis C virus patients in Spain

Enfermedades infecciosas y microbiologia clinica (English ed.), 2018-05, Vol.36 (5), p.262-267

2018

Volltextzugriff (PDF)

Off-label use of rilpivirine in combination with emtricitabine and tenofovir in HIV-1-infected pediatric patients: A multicenter study

Medicine (Baltimore), 2016-06, Vol.95 (24), p.e3842-e3842

2016

Volltextzugriff (PDF)

1 – 25 von 104

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(89)
Mit Volltextzugriff
(90)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(71)
Humans
(56)
Life Sciences & Biomedicine
(55)
Female
(32)
Male
(30)
Child
(20)
Middle Aged
(17)
Hiv
(16)
Child, Preschool
(15)
Infectious Diseases
(15)
Adolescent
(14)
Biological And Medical Sciences
(14)
Adult
(13)
Immunology
(13)
Medical Sciences
(13)
Hiv Infections - Drug Therapy
(12)
Hiv Infections - Virology
(12)
Multidisciplinary Sciences
(12)
Pediatrics
(12)
Science & Technology - Other Topics
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Impact of the 2008 economic crisis on the burden of hepatitis B and C diseases in Southern European countries

Epidemic history of hepatitis C virus genotypes and subtypes in Portugal

HIV-1 diversity, transmission dynamics and primary drug resistance in Angola

Early infant diagnosis of HIV-1 infection in Luanda, Angola, using a new DNA PCR assay and dried blood spots

Long-Term and Low-Level Envelope C2V3 Stimulation by Highly Diverse Virus Isolates Leads to Frequent Development of Broad and Elite Antibody Neutralization in HIV-1-Infected Individuals

Low frequency of NS5A relevant resistance-associated substitutions to Elbasvir among hepatitis C virus genotype 1a in Spain: a cross-sectional study

Predictors of attrition and immunological failure in HIV-1 patients on highly active antiretroviral therapy from different healthcare settings in Mozambique

A Conserved GPG-Motif in the HIV-1 Nef Core Is Required for Principal Nef-Activities

Dynamics of HIV Reservoir and HIV-1 Viral Splicing in HCV-Exposed Individuals after Elimination with DAAs or Spontaneous Clearance

Different HCV Exposure Drives Specific miRNA Profile in PBMCs of HIV Patients

Determinants of highly active antiretroviral therapy duration in HIV-1-infected children and adolescents in Madrid, Spain, from 1996 to 2012

Scorpion envenomation in Argentina

HIV-1 drug resistance and genetic diversity in people with HIV-1 in Cape Verde

Prioritizing the most needed formulations to accelerate paediatric antiretroviral therapy scale-up

Envenenamiento por escorpión en la Argentina

Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention

Impact of highly active antiretroviral therapy (HAART) on clinical outcomes of vertically HIV-1 infected children

Epidemic history and baseline resistance to NS5A-specific direct acting drugs of hepatitis C virus in Spain

Spatial pattern of HIV-1 cases of vertical transmission in Madrid (Spain): impact of demographic and socioeconomic factors

HCV-coinfection is related to an increased HIV-1 reservoir size in cART-treated HIV patients: a cross-sectional study

Frecuencia de sustituciones relevantes asociadas a resistencia en la región NS5A a elbasvir en el virus de la hepatitis C en pacientes con genotipo 1a en España

Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019

Off-label use of maraviroc in HIV-1-infected paediatric patients in clinical practice

Prevalence of relevant NS5A resistance-associated substitutions to elbasvir in genotype 1a hepatitis C virus patients in Spain

Off-label use of rilpivirine in combination with emtricitabine and tenofovir in HIV-1-infected pediatric patients: A multicenter study

Suchergebnisse filtern